Qelbree, a relatively new addition to the non-stimulant category, offers a promising alternative with its FDA approval for both children and adults.

Guanfacine and its extended-release formulation, Guanfacine ER (Intuniv), are medications primarily used in the treatment of attention deficit hyperactivity disorder (ADHD).